Studying fever illness care in DRC
Part of Infections clinical trials.
This study is looking at how to better care for people with fever in the Democratic Republic of the Congo. If you have a fever now or very recently, you may be able to join and help doctors learn more about it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a fever now, or you had a fever at home or a health center in the past 24 hours.
- You can check in with the study team on days 7, 14, and 21.
- You or your family member can sign a consent form (children 12–17 also give their okay if possible).
- You must be at least 2 months old.
- You have not been in the hospital for more than 48 hours in the last 14 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at babies 60 days or younger who have a fever of 100.4°F or higher. It aims to better understand and manage fevers in young infants.
This study looks for antibiotic-resistant bacteria in the blood of patients with a suspected bloodstream infection. The goal is to understand which antibiotics still work, helping doctors choose the right treatment.
This trial looks at different ways to control mosquitoes that spread diseases. It will see how well these methods work in households and health facilities in Kinshasa.
This study is for people with a recent fever. Researchers want to learn more about what causes fevers in Guinea and how to treat them. You would need to be able to come back for check-ups over 3 weeks.
This study looks at why people develop fever and what outcomes they have after they are seen in rural health facilities. It may help improve how clinics recognize and manage fever illnesses.
This study looks at adults with a fever caused by a respiratory infection. If you qualify, you will have a blood draw as part of your regular care, and researchers will use it to learn more about your condition.
Hear when a new Surveillance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.